Dr. Brooks is the Chief Medical Officer for Rapid Response Revival, manufacturers of CellAED, the world's first personal automated external defibrillator. Dr. Brooks is a clinician scientist in the Department of Emergency Medicine at Queen's University. After graduating from Queen's School of Medicine in 2001, Dr. Brooks completed a Royal College of Physicians and Surgeons of Canada residency in emergency medicine, and Masters of Health Sciences degree at the University of British Columbia. He then moved to the University of Toronto where he completed a fellowship in pre-hospital and transport medicine. Dr. Brooks' academic focus is cardiac arrest and resuscitation. He has published 111 manuscripts which have been cited more than 10,000 times in the medical literature. He has been awarded over $24 million (CDN) in grant funding. His work focuses on innovative technologies and strategies designed to increase bystander cardiopulmonary resuscitation and improve access to early defibrillation. He is the Principal Investigator on two clinical trials which are actively recruiting. The PulsePoint randomised controlled trial is a multi-site, international evaluation of a mobile device application that crowdsources basic life support for cardiac arrest. The 'Neighbours Saving Neighbours' study is evaluating a novel strategy for rural communities involving CPR-trained and defibrillator-equipped community volunteers responding in parallel with paramedics to cardiac arrest emergencies in their neighbourhoods. Dr. Brooks has been involved in the development of international emergency cardiovascular care guidelines for the last 20 years. Dr. Brooks is a member of the Resuscitation Advisory Committee of the Heart and Stroke Foundation of Canada, and the Immediate Past Chair of the Science Subcommittee within the American Heart Association Emergency Cardiovascular Care Committee.